David C. Bean - Concepedia

Author

David C. Bean

Queen Mary University of London ORCID

Also Known As

Bean, David, D Bean, D C BEAN, D. Bean, D. C. Bean, D.C. Bean, DC Bean, David Bean, David C Bean, David C. Bean

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Queen Mary University of London Federation University Barts Health NHS Trust University of Canterbury Homerton University Hospital NHS Foundation Trust

About

David C. Bean is an author at Queen Mary University of London specializing in microbiology, medicine, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Microbiology	6	6	298
2	Medicine	5	5	277
3	Health Sciences	4	4	240
4	Public Health	1	1	21
5	Epidemiology	1	1	15

David C. Bean

Publications

880

Citations

H-Index

Page 1

	Year	Citations
Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005 – 2006 David C. Bean, D. Krahé, David W. Wareham Annals of Clinical Microbiology and Antimicrobials	2008	172
Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance David W. Wareham, David C. Bean, Priyanka Khanna, European Journal of Clinical Microbiology & Infectious Diseases Bloodstream InfectionAntimicrobial SusceptibilityHealth SciencesAntibioticsAcinetobacter Spp	2008	122
Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man David C. Bean, David M. Livermore, Iro Papa, Journal of Antimicrobial Chemotherapy	2005	117
Plasmids Imparting Sulfonamide Resistance in <i>Escherichia coli</i> : Implications for Persistence David C. Bean, David M. Livermore, Lucinda M. C. Hall Antimicrobial Agents and Chemotherapy Antimicrobial Resistance GeneAntimicrobial SusceptibilityHealth SciencesAntibioticsDrug Resistance	2008	82
In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases. David W. Wareham, David C. Bean Annals of Clinical Microbiology and Antimicrobials	2006	66
CHROMagar COL-APSE: a selective bacterial culture medium for the isolation and differentiation of colistin-resistant Gram-negative pathogens Muhd Haziq F. Abdul Momin, David C. Bean, René S. Hendriksen, Journal of Medical Microbiology	2017	52
Investigations into the in vitro antimicrobial activity and mode of action of the phenazine antibiotic d-alanylgriseoluteic acid Stephen R. Giddens, David C. Bean International Journal of Antimicrobial Agents Medicinal ChemistryAntifungal AgentAntibioticsMedicineAntibacterial Agent	2006	47
Carriage rate and antibiotic susceptibility of coagulase‐positive staphylococci isolated from healthy dogs in Victoria, Australia David C. Bean, SM Wigmore Australian Veterinary Journal	2016	42
Antimicrobial Activity of Extracts from Native Plants of Temperate Australia Sarah M. Wigmore, Mani Naiker, David C. Bean Pharmacognosy Communications	2016	24
Hypermucoviscous polymyxin-resistant Klebsiella pneumoniae from Kolkata, India: Genomic and phenotypic analysis David C. Bean, Anuradha Agarwal, Benny P. Cherian, Journal of Global Antimicrobial Resistance	2019	24

Page 1